The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Open accessAbstract
Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily affecting men 20-60 years of age. To date, no consensus has been reached regarding the classification of CSC, and a wide variety of interventions have been proposed, reflecting the controversy associated with treating this disease. The recent publication of appropriately powered randomised controlled trials such as the PLACE trial, as well as large retrospective, non-randomised treatment studies regarding the treatment of CSC suggest the feasibility of a more evidence-based approach when considering treatment options. The aim of this review is to provide a comprehensive overview of the current rationale and evidence with respect to the variety of interventions available for treating CSC, including pharmacology, laser treatment, and photodynamic therapy. In addition, we describe the complexity of CSC, the challenges associated with treating CSC, and currently ongoing studies. Many treatment strategies such as photodynamic therapy using verteporfin, oral mineralocorticoid antagonists, and micropulse laser treatment have been reported as being effective. Currently, however, the available evidence suggests that half-dose (or half-fluence) photodynamic therapy should be the treatment of choice in chronic CSC, whereas observation may be the preferred approach in acute CSC. Nevertheless, exceptions can be considered based upon patient-specific characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
Bhutto, I., & Lutty, G. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.005 · Cited by 1,005
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.003 · Cited by 989
IMAMURA, Y., FUJIWARA, T., MARGOLIS, R., & SPAIDE, R. F. (2009) · Retina · doi:10.1097/iae.0b013e3181be0a83 · Cited by 955
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
Yannuzzi, L. A., Sorenson, J., Spaide, R. F., & Lipson, B. (2012) · Retina · doi:10.1097/iae.0b013e31823f992a · Cited by 753
Self-citationCentral serous chorioretinopathy
Wang, M., Munch, I. C., Hasler, P. W., Prünte, C., & Larsen, M. (2008) · Acta Ophthalmologica · doi:10.1111/j.1600-0420.2007.00889.x · Cited by 726
Self-citationCheung, C. M. G., Lee, W. K., Koizumi, H., Dansingani, K. K., Lai, T. Y. Y., & Freund, K. B. (2018) · Eye · doi:10.1038/s41433-018-0158-4 · Cited by 650
Self-citationCentral Serous Chorioretinopathy: Update on Pathophysiology and Treatment
Nicholson, B., Noble, J., Forooghian, F., & Meyerle, C. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.07.004 · Cited by 649
INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY
SPAIDE, R. F., YANNUZZI, L. A., SLAKTER, J. S., SORENSON, J., & ORLACH, D. A. (1995) · Retina · doi:10.1097/00006982-199515020-00003 · Cited by 608
Self-citationIDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
YANNUZZI, L. A., SORENSON, J., SPAIDE, R. F., & LIPSON, B. (1990) · Retina · doi:10.1097/00006982-199010010-00001 · Cited by 588
Self-citationCentral Serous Chorioretinopathy in Younger and Older Adults
Spaide, R. F., Campeas, L., Haas, A., Yannuzzi, L. A., Fisher, Y. L., Guyer, D. R., Slakter, J. S., Sorenson, J. A., & Orlock, D. A. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30386-2 · Cited by 551
Self-citationSchmidt-Erfurth, U., & Hasan, T. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00158-2 · Cited by 518
TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY
YANNUZZI, L. A. (1987) · Retina · doi:10.1097/00006982-198700720-00009 · Cited by 504
Self-citationRisk factors for central serous chorioretinopathy
Haimovici, R., Koh, S., Gagnon, D. R., Lehrfeld, T., & Wellik, S. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.09.024 · Cited by 475
The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002
Kitzmann, A. S., Pulido, J. S., Diehl, N. N., Hodge, D. O., & Burke, J. P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.02.032 · Cited by 466
RU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses
Cadepond, P., Ulmann, M., & Baulieu, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.129 · Cited by 424
Polypoidal Choroidal Vasculopathy
Cheung, C. M. G., Lai, T. Y. Y., Ruamviboonsuk, P., Chen, S.-J., Chen, Y., Freund, K. B., Gomi, F., Koh, A. H., Lee, W.-K., & Wong, T. Y. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.11.019 · Cited by 396
Self-citationSpectral-Domain Optical Coherence Tomography Angiography of Choroidal Neovascularization
de Carlo, T. E., Bonini Filho, M. A., Chin, A. T., Adhi, M., Ferrara, D., Baumal, C. R., Witkin, A. J., Reichel, E., Duker, J. S., & Waheed, N. K. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.01.029 · Cited by 394
Yannuzzi, L. A., Slakter, J. S., GROSS, N. E., Spaide, R. F., COSTA, D. L. L., Huang, S. J., Klancnik, J. M., & Aizman, A. (2003) · Retina · doi:10.1097/00006982-200306000-00002 · Cited by 387
Self-citationMineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
Zhao, M., Célérier, I., Bousquet, E., Jeanny, J.-C., Jonet, L., Savoldelli, M., Offret, O., Curan, A., Farman, N., Jaisser, F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61427 · Cited by 383
Systemic findings associated with central serous chorioretinopathy
Tittl, M. K., Spaide, R. F., Wong, D., Pilotto, E., Yannuzzi, L. A., Fisher, Y. L., Freund, B., Guyer, D. R., Slakter, J. S., & Sorenson, J. A. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00075-6 · Cited by 382
Self-citationvan Dijk, E. H. C., Fauser, S., Breukink, M. B., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.021 · Cited by 351
Self-citationThe spectrum of ocular phenotypes caused by mutations in the BEST1 gene
Boon, C. J. F., Klevering, B. J., Leroy, B. P., Hoyng, C. B., Keunen, J. E. E., & den Hollander, A. I. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.04.002 · Cited by 348
Self-citationA HISTORY OF PHOTODYNAMIC THERAPY
Daniell, M. D., & Hill, J. S. (1991) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1991.tb00230.x · Cited by 341
Central serous chorioretinopathy: an update on pathogenesis and treatment
Gemenetzi, M., De Salvo, G., & Lotery, A. J. (2010) · Eye · doi:10.1038/eye.2010.130 · Cited by 325
Self-citationOCT angiography and evaluation of the choroid and choroidal vascular disorders
Borrelli, E., Sarraf, D., Freund, K. B., & Sadda, S. R. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.07.002 · Cited by 321
Self-citationThe foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy
Piccolino, F. C., de la Longrais, R. R., Ravera, G., Eandi, C. M., Ventre, L., Abdollahi, A. A., & Manea, M. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.08.037 · Cited by 315
Self-citationCHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY
Agrawal, R., Chhablani, J., Tan, K.-A., Shah, S., Sarvaiya, C., & Banker, A. (2016) · Retina · doi:10.1097/iae.0000000000001040 · Cited by 311
Self-citationKoh, A., Lai, T. Y. Y., Takahashi, K., Wong, T. Y., Chen, L.-J., Ruamviboonsuk, P., Tan, C. S., Feller, C., Margaron, P., Lim, T. H., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.4030 · Cited by 301
Self-citationSchlötzer-Schrehardt, U., Viestenz, A., Naumann, G. O., Laqua, H., Michels, S., & Schmidt-Erfurth, U. (2002) · Graefe’s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-002-0517-4 · Cited by 278
Lee, W. K., Iida, T., Ogura, Y., Chen, S.-J., Wong, T. Y., Mitchell, P., Cheung, G. C. M., Zhang, Z., Leal, S., Ishibashi, T., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.1804 · Cited by 276
Type A Behavior and Elevated Physiological and Neuroendocrine Responses to Cognitive Tasks
Williams, R. B., Lane, J. D., Kuhn, C. M., Melosh, W., White, A. D., & Schanberg, S. M. (1982) · Science · doi:10.1126/science.7123248 · Cited by 271
Yannuzzi, L. A., Shakin, J. L., Fisher, Y. L., & Altomonte, M. A. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34117-3 · Cited by 269
Self-citationO'Keefe, G. A. D., & Rao, N. A. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2016.05.002 · Cited by 268
Mehta, H., Tufail, A., Daien, V., Lee, A. Y., Nguyen, V., Ozturk, M., Barthelmes, D., & Gillies, M. C. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.12.002 · Cited by 265
Fung, A. T., Yannuzzi, L. A., & Freund, K. (2012) · Retina · doi:10.1097/iae.0b013e3182680a66 · Cited by 250
Self-citationCentral Serous Chorioretinopathy in Endogenous Hypercortisolism
Bouzas, E. A. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090090081024 · Cited by 243
Sunness, J. S. (1988) · Survey of Ophthalmology · doi:10.1016/0039-6257(88)90172-5 · Cited by 242
In Vivo Human Choroidal Thickness Measurements: Evidence for Diurnal Fluctuations
Brown, J. S., Flitcroft, D. I., Ying, G.-S., Francis, E. L., Schmid, G. F., Quinn, G. E., & Stone, R. A. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1779 · Cited by 241
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy
Mrejen, S., Balaratnasingam, C., Kaden, T. R., Bottini, A., Dansingani, K., Bhavsar, K. V., Yannuzzi, N. A., Patel, S., Chen, K. C., Yu, S., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.12.048 · Cited by 240
Self-citationCentral Serous Chorioretinopathy: A Personal Perspective
Yannuzzi, L. A. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.11.017 · Cited by 238
Self-citationHistory of Photodynamic Therapy
Abdel-Kader, M. H. (2014) · Photodynamic Therapy · doi:10.1007/978-3-642-39629-8_1 · Cited by 231
Miller, J. W. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060136048 · Cited by 227
Fundus Autofluorescence and Central Serous Chorioretinopathy
SPAIDE, R., & KLANCNIKJR, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.01.003 · Cited by 226
Liposomal Benzoporphyrin Derivative Verteporfin Photodynamic Therapy
Kramer, M., Miller, J. W., Michaud, N., Moulton, R. S., Hasan, T., Flotte, T. J., & Gragoudas, E. S. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30675-1 · Cited by 221
CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
IIDA, T., YANNUZZI, L. A., SPAIDE, R. F., BORODOKER, N., CARVALHO, C. A., & NEGRÃO, S. (2003) · RETINA · doi:10.1097/00006982-200302000-00001 · Cited by 215
Self-citationBousquet, E., Beydoun, T., Zhao, M., Hassan, L., Offret, O., & Behar-Cohen, F. (2013) · Retina · doi:10.1097/iae.0b013e318297a07a · Cited by 212
AUTOFLUORESCENCE FROM THE OUTER RETINA AND SUBRETINAL SPACE: Hypothesis and Review
SPAIDE, R. (2008) · Retina · doi:10.1097/iae.0b013e318158eca4 · Cited by 208
Pang, C. E., Shah, V. P., Sarraf, D., & Freund, K. B. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.04.021 · Cited by 208
Self-citationMineralocorticoid receptor antagonists: The evolution of utility and pharmacology
Delyani, J. A. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00983.x · Cited by 206
Endogenous cortisol profile in patients with central serous chorioretinopathy
Garg, S. P., Dada, T., Talwar, D., & Biswas, N. R. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.11.962 · Cited by 202
Ferrara, D., Mohler, K. J., Waheed, N., Adhi, M., Liu, J. J., Grulkowski, I., Kraus, M. F., Baumal, C., Hornegger, J., Fujimoto, J. G., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.014 · Cited by 189
New hypotheses on the pathogenesis and treatment of serous retinal detachment
Marmor, M. F. (1988) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02169203 · Cited by 187
Chan, W.-M., Lai, T. Y. Y., Liu, D. T. L., & Lam, D. S. C. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.02.039 · Cited by 167
Self-citationZhao, M., Valamanesh, F., Celerier, I., Savoldelli, M., Jonet, L., Jeanny, J., Jaisser, F., Farman, N., & Behar‐Cohen, F. (2010) · The FASEB Journal · doi:10.1096/fj.09-154344 · Cited by 166
Central Serous Chorioretinopathy Associated with Inhaled or Intranasal Corticosteroids
Haimovici, R., Gragoudas, E. S., Duker, J. S., Sjaarda, R. N., & Eliott, D. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30082-7 · Cited by 164
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
Breukink, M. B., Dingemans, A. J., den Hollander, A. I., Keunen, J. E., MacLaren, R. E., Fauser, S., Querques, G., Hoyng, C. B., Downes, S. M., & Boon, C. J. (2016) · Clinical Ophthalmology · doi:10.2147/opth.s115685 · Cited by 158
Self-citationInterventions for central serous chorioretinopathy: a network meta-analysis
Salehi, M., Wenick, A. S., Law, H. A., Evans, J. R., & Gehlbach, P. L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011841.pub2 · Cited by 152
Pandi-Perumal, S. R., Trakht, I., Spence, D. W., Srinivasan, V., Dagan, Y., & Cardinali, D. P. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0847 · Cited by 151
Non-damaging Retinal Phototherapy: Dynamic Range of Heat Shock Protein Expression
Sramek, C., Mackanos, M. A., Spitler, R., Leung, L.-S. B., Nomoto, H., Contag, C. H., & Palanker, D. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5917 · Cited by 146
Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.059 · Cited by 145
Kozak, I., Oster, S. F., Cortes, M. A., Dowell, D., Hartmann, K. I., Kim, J. S., & Freeman, W. R. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.10.007 · Cited by 142
de Jong, E. K., Breukink, M. B., Schellevis, R. L., Bakker, B., Mohr, J. K., Fauser, S., KEUNEN, J. E. E., Hoyng, C. B., den Hollander, A. I., & Boon, C. J. F. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.026 · Cited by 141
Self-citationKoizumi, H., Kano, M., Yamamoto, A., Saito, M., Maruko, I., Sekiryu, T., Okada, A. A., & Iida, T. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.039 · Cited by 141
Clinical and Morphologic Characteristics of MEK Inhibitor–Associated Retinopathy
Francis, J. H., Habib, L. A., Abramson, D. H., Yannuzzi, L. A., Heinemann, M., Gounder, M. M., Grisham, R. N., Postow, M. A., Shoushtari, A. N., Chi, P., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.038 · Cited by 141
Self-citationTransient MEK inhibitor-associated retinopathy in metastatic melanoma
Urner-Bloch, U., Urner, M., Stieger, P., Galliker, N., Winterton, N., Zubel, A., Parseval, L. M., Dummer, R., & Goldinger, S. M. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu169 · Cited by 135
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY
Bousquet, E., Beydoun, T., Rothschild, P.-R., Bergin, C., Zhao, M., Batista, R., Brandely, M.-L., Couraud, B., Farman, N., Gaudric, A., et al. (2015) · Retina · doi:10.1097/iae.0000000000000614 · Cited by 135
Lai, T. Y. Y., Staurenghi, G., Lanzetta, P., Holz, F. G., Liew, S. H. M., Desset-Brèthes, S., Staines, H., Hykin, P. G., & on behalf of the MINERVA study group (2017) · Retina · doi:10.1097/iae.0000000000001744 · Cited by 133
Self-citationMiki, A., Kondo, N., Yanagisawa, S., Bessho, H., Honda, S., & Negi, A. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.020 · Cited by 128
Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.
Polak, B. C. P., Baarsma, G. S., & SNYERS, B. (1995) · British Journal of Ophthalmology · doi:10.1136/bjo.79.10.922 · Cited by 127
Autosomal Recessive Bestrophinopathy
Boon, C. J. F., van den Born, L. I., Visser, L., KEUNEN, J. E. E., Bergen, A. A. B., Booij, J. C., Riemslag, F. C. C., Florijn, R. J., & van Schooneveld, M. J. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.057 · Cited by 125
Self-citationDadgostar, H., Ventura, A. A. C. M., Chung, J. Y., Sharma, S. K., & Kaiser, P. K. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.05.033 · Cited by 125
Photodynamic therapy: current role in the treatment of chorioretinal conditions
Newman, D. K. (2016) · Eye · doi:10.1038/eye.2015.251 · Cited by 124
Experimental Serous Retinal Detachment and Focal Pigment Epithelial Damage
Negi, A., & Marmor, M. F. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030359038 · Cited by 119
Hosoda, Y., Yoshikawa, M., Miyake, M., Tabara, Y., Ahn, J., Woo, S. J., Honda, S., Sakurada, Y., Shiragami, C., Nakanishi, H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802212115 · Cited by 112
INTRAVITREAL BEVACIZUMAB INJECTION FOR CENTRAL SEROUS CHORIORETINOPATHY
Lim, S. J., Roh, M., & Kwon, O. W. (2010) · Retina · doi:10.1097/iae.0b013e3181bcf0b4 · Cited by 109
PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
Cook, C. S., Berry, L., Bible, R. H., Hribar, J. D., Hajdu, E., & Liu, N. W. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1448 · Cited by 107
Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy
Schubert, C., Pryds, A., Zeng, S., Xie, Y., Freund, K. B., Spaide, R. F., Merriam, J. C., BARBAZETTO, I. A., Slakter, J. S., Chang, S., et al. (2014) · Human Mutation · doi:10.1002/humu.22551 · Cited by 105
Self-citationTittl, M., Maár, N., Polska, E., Weigert, G. ̈., Stur, M., & Schmetterer, L. F. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0268 · Cited by 102
On the origin of proteins in human drusen: The meet, greet and stick hypothesis
Bergen, A. A., Arya, S., Koster, C., Pilgrim, M. G., Wiatrek-Moumoulidis, D., van der Spek, P. J., Hauck, S. M., Boon, C. J. F., Emri, E., Stewart, A. J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.12.003 · Cited by 101
Self-citationChung, Y.-R., Seo, E. J., Lew, H. M., & Lee, K. (2013) · Eye · doi:10.1038/eye.2013.236 · Cited by 100
Ersöz, M. G., Arf, S., Hocaoğlu, M., et al. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-312431 · Cited by 100
Ting, D. S. W., Ng, W. Y., Ng, S. R., Tan, S. P., Yeo, I. Y. S., Mathur, R., Chan, C. M., Tan, A. C. S., Tan, G. S. W., Wong, T. Y., et al. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.12.024 · Cited by 99
Groups, T. O. A.-R. M. D. W. P. T. (. A. V. I. P. T. (. S. (2004) · Retina · doi:10.1097/00006982-200402000-00001 · Cited by 97
Grover, S., Fishman, G. A., Fiscella, R. G., et al. (1997) · Retina · doi:10.1097/00006982-199705000-00009 · Cited by 97
Daruich, A., Matet, A., Dirani, A., Gallice, M., Nicholson, L., Sivaprasad, S., & Béhar‐Cohen, F. (2016) · Translational Vision Science & Technology · doi:10.1167/tvst.5.2.2 · Cited by 97
Self-citationRahimy, E., Pitcher, J. D., Hsu, J., Adam, M. K., Shahlaee, A., Samara, W. A., VANDER, J. F., Kaiser, R. S., Chiang, A., Spirn, M. J., et al. (2017) · Retina · doi:10.1097/iae.0000000000001649 · Cited by 97
Bae, S. H., Heo, J. W., Kim, C., Kim, T. W., Lee, J. Y., Song, S. J., Park, T. K., Moon, S. W., & Chung, H. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.04.008 · Cited by 96
Retinal Pigment Epithelium Decompensation
Jalkh, A. E., Jabbour, N., de Ávila, M. P., Trempe, C. L., & Schepens, C. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34095-7 · Cited by 95
COSCAS, G. J., Lupidi, M., Coscas, F., Benjelloun, F., Zerbib, J., Dirani, A., Semoun, O., & Souied, E. H. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16236 · Cited by 89
Low-Fluence Photodynamic Therapy versus Ranibizumab for Chronic Central Serous Chorioretinopathy
Bae, S. H., Heo, J., Kim, C., Kim, T. W., Shin, J. Y., Lee, J. Y., Song, S. J., Park, T. K., Moon, S. W., & Chung, H. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.024 · Cited by 89
RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY
Matet, A., Daruich, A., Zola, M., & Béhar‐Cohen, F. (2017) · Retina · doi:10.1097/iae.0000000000001729 · Cited by 84
Systemic Factors Associated with Central Serous Chorioretinopathy in Koreans
Eom, Y., Oh, J., Kim, S., & Huh, K. (2012) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2012.26.4.260 · Cited by 83
Glucocorticoid Receptor Antagonists
Clark, R. D. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608784535011 · Cited by 82
van Dijk, E. H. C., van Herpen, C. M. L., Marinkovic, M., Haanen, J. B. A. G., Amundson, D., Luyten, G. P. M., Jager, M. J., Kapiteijn, E. H. W., Keunen, J. E. E., Adamus, G., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.05.027 · Cited by 79
Self-citationTogni, S., & Mazzolani, F. (2013) · Clinical ophthalmology · doi:10.2147/opth.s45820 · Cited by 77
van Dijk, E. H. C., Schellevis, R. L., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0245 · Cited by 76
Self-citationShift Work: A Risk Factor for Central Serous Chorioretinopathy
Bousquet, E., Dhundass, M., Lehmann, M., Rothschild, P.-R., Bayon, V., Léger, D., Bergin, C., Dirani, A., Beydoun, T., & Béhar‐Cohen, F. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.02.012 · Cited by 75
CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS
Ghadiali, Q., Jung, J. J., Yu, S., PATEL, S. N., & Yannuzzi, L. A. (2015) · Retina · doi:10.1097/iae.0000000000000748 · Cited by 74
Self-citationConrad, R., Geiser, F., Kleiman, A., Zur, B., & Godt, A. K. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/631687 · Cited by 72
Pitcher, J. D., Witkin, A. J., DeCroos, F. C., & Ho, A. C. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306018 · Cited by 71
Schellevis, R. L., van Dijk, E. H. C., Breukink, M. B., Altay, L., Bakker, B., Koeleman, B. P. C., Kiemeney, L. A. L. M., Swinkels, D. W., KEUNEN, J. E. E., Fauser, S., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.3190 · Cited by 71
Self-citationThe Central Serous Chorioretinopathy Study Group, Pichi, F., Carrai, P., Ciardella, A. P., Béhar‐Cohen, F., & Nucci, P. (2016) · International Ophthalmology · doi:10.1007/s10792-016-0377-2 · Cited by 69
Photodynamic Therapy of Subretinal Neovascularization in the Monkey Eye
Miller, H., & Miller, B. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090060145039 · Cited by 64
Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
Piccolino, F. C., Lupidi, M., Cagini, C., Fruttini, D., Nicolò, M., Eandi, C. M., & Tito, S. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-23995 · Cited by 64
Self-citationClinical experience with eplerenone to treat chronic central serous chorioretinopathy
Cakir, B., Fischer, F., Ehlken, C., Bühler, A., Stahl, A., Schlunck, G., Böhringer, D., Agostini, H. T., & Lange, C. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3373-3 · Cited by 63
van Rijssen, T. J., van Dijk, E. H. C., Scholz, P., Breukink, M. B., Blanco-Garavito, R., Souied, E. H., KEUNEN, J. E. E., MacLaren, R. E., Querques, G., Fauser, S., et al. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2019.03.025 · Cited by 63
Self-citationInhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume
Wolfensberger, T. J., Dmitriev, A. V., & GOVARDOVSKII, V. I. (1999) · Documenta Ophthalmologica · doi:10.1023/a:1002496223131 · Cited by 62
Gergely, R., Kovács, I., Schneider, M., Resch, M., Papp, A., Récsán, Z., Nagy, Z. Z., & Ecsedy, M. (2016) · Retina · doi:10.1097/iae.0000000000001303 · Cited by 61
Chhablani, J. K., Kozak, I., Pichi, F., Chenworth, M. L., Berrocal, M. H., Bedi, R., Singh, R. P., Wu, L., MEYERLE, C. B., Casella, A., et al. (2015) · Retina · doi:10.1097/iae.0000000000000655 · Cited by 60
Self-citationSoomro, T., & Talks, J. S. (2018) · Eye · doi:10.1038/eye.2018.2 · Cited by 59
Phthalocyanine Photodynamic Therapy of Experimental Iris Neovascularization
Miller, J. W., Stinson, W. G., Gregory, W. A., El-Koumy, H. A., & Puliafito, C. A. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32079-7 · Cited by 58
Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis
Ji, S., Wei, Y., Chen, J., & Tang, S. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0460-4 · Cited by 58
Peters, S., Julien, S., Heiduschka, P., Grisanti, S., Ziemssen, F., Adler, M., Schraermeyer, U., Bartz‐Schmidt, K. U., & the Tuebingen Bevacizumab Study Group (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.109702 · Cited by 57
Han, J. M., Hwang, J., Kim, J. S., Park, K. H., & Woo, S. J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12854 · Cited by 56
Spironolactone in the treatment of central serous chorioretinopathy – a case series
Herold, T., Prause, K., Wolf, A., Mayer, W. J., & ULBIG, M. W. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2780-6 · Cited by 55
Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
Chin, E. K., Almeida, D. R. P., Roybal, C. N., Niles, P. I., Gehrs, K. M., Sohn, E. H., Boldt, H. C., Russell, S. R., & Folk, J. C. (2015) · Clinical ophthalmology · doi:10.2147/opth.s86778 · Cited by 52
Oral eplerenone for the management of chronic central serous chorioretinopathy
Rishi, R., Singh, Jonathan, J., et al. (2015) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 48
Breukink, M. B., Schellevis, R. L., Boon, C. J. F., Fauser, S., Hoyng, C. B., den Hollander, A. I., & de Jong, E. K. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17343 · Cited by 46
Self-citationOral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy
Steinle, N. C., Gupta, N., Yuan, A., & Singh, R. P. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300183 · Cited by 46
Dang, Y., Mu, Y., Zhao, M., et al. (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s50407 · Cited by 45
van Rijssen, T. J., Mohabati, D., Dijkman, G., Theelen, T., de Jong, E. K., van Dijk, E. H. C., & Boon, C. J. F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202549 · Cited by 44
Self-citationIntravitreal Ranibizumab for Acute Central Serous Chorioretinopathy
Kim, M., Lee, S.-C., & Lee, S.-J. (2012) · Ophthalmologica · doi:10.1159/000345495 · Cited by 43
Siegfried, F., Rommel, F., Rothe, M., Brinkmann, M. P., Sochurek, J. A. M., Freitag, J. C., Grisanti, S., & Ranjbar, M. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14140 · Cited by 43
Poor Sleep Quality Is the Risk Factor for Central Serous Chorioretinopathy
Ji, Y., Li, M., Zhang, X., Peng, Y., & Wen, F. (2018) · Journal of Ophthalmology · doi:10.1155/2018/9450297 · Cited by 42
Ziemssen, F., & Heimann, H. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.701617 · Cited by 41
Lai, T. Y. Y., Wong, R. L. M., & Chan, W. (2015) · Europe PMC (PubMed Central) · Cited by 38
Self-citationNourinia, R., Ahmadieh, H., Nekoei, E., Malekifar, P., & Tofighi, Z. (2017) · Retina · doi:10.1097/iae.0000000000001645 · Cited by 37
Kim, Y., Woo, S. J., Park, K. H., Chi, Y. K., Han, J. W., & Kim, K. W. (2018) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2017.0144 · Cited by 36
Is myopia a protective factor against central serous chorioretinopathy?
Manayath, G. J., Arora, S., Parikh, H., Shah, P. K., Tiwari, S., & Narendran, V. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.02.16 · Cited by 35
Chronic Central Serous Chorioretinopathy as a Presenting Symptom of Cushing Syndrome
van Dijk, E. H. C., Dijkman, G., Biermasz, N. R., van Haalen, F. M., Pereira, A. M., & Boon, C. J. F. (2016) · European Journal of Ophthalmology · doi:10.5301/ejo.5000790 · Cited by 35
Self-citationHerold, T., Rist, K., Priglinger, S. G., ULBIG, M. W., & Wolf, A. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3436-5 · Cited by 34
Zola, M., Chatziralli, I., Menon, D., Schwartz, R., Hykin, P., & Sivaprasad, S. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13742 · Cited by 34
Self-citationBrinks, J., van Dijk, E. H. C., Habeeb, M., Nikolaou, A. I., Tsonaka, R., Peters, H. A. B., Sips, H. C. M., van de Merbel, A. F., de Jong, E. K., Notenboom, R. G. E., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25054 · Cited by 33
Self-citationJang, L., Gianniou, C., Ambresin, A., & Mantel, I. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2789-x · Cited by 32
van Haalen, F. M., van Dijk, E. H. C., Andela, C. D., Dijkman, G., Biermasz, N. R., Pereira, A. M., & Boon, C. J. F. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13952 · Cited by 31
Self-citationTogni (2012) · Clinical ophthalmology · doi:10.2147/opth.s31859 · Cited by 25
Circadian disturbance and idiopathic central serous chorioretinopathy
Setrouk, É., HUBAULT, B., Vankemmel, F., Zambrowski, O., Nazeyrollas, P., Delemer, B., Durlach, V., Ducasse, A., & Arndt, C. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3378-y · Cited by 22
Long-term follow-up of an ophthalmologist's central serous retinopathy, photocoagulated by sungazing
G�rtner, J. (1987) · Documenta Ophthalmologica · doi:10.1007/bf00144736 · Cited by 17
Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy
Copete, S., Ruiz‐Moreno, J. M., Cava, C. F. L., & Montero, J. A. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1900-9 · Cited by 16
Casalino, G., Turco, C. D., Corvi, F., Rafaeli, O., Bandello, F. M., & Querques, G. (2016) · Ophthalmic Research · doi:10.1159/000444328 · Cited by 16
Self-citationO’Connell, A., Culliford, L. A., Ellis, L. A., Rogers, C. A., Cree, A. J., Chakravarthy, U., Ennis, S., Béhar‐Cohen, F., Reeves, B. C., Sivaprasad, S., et al. (2018) · Eye · doi:10.1038/s41433-018-0212-2 · Cited by 16
Self-citationCentral Serous Chorioretinopathy: Clinical Characteristics Associated with Visual Outcomes
Nicholson, B. P., Idris, A. A., & Bakri, S. J. (2018) · Seminars in Ophthalmology · doi:10.1080/08820538.2018.1503690 · Cited by 13
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
Cuevas, P., Outeiriño, L. A., Azanza, C., Angulo, J., & Giménez‐Gallego, G. (2012) · European journal of medical research · doi:10.1186/2047-783x-17-22 · Cited by 13
Visual Cycle Suppression via Patching in Central Serous Chorioretinopathy
Earl, J. B., Lee, C. S., Yom, V. H., Stavern, G. P. V., Abuattieh, M., Chin-Yee, D., Rao, P. K., & Apte, R. S. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.06.038 · Cited by 10
Kim, J. Y., Chae, J. B., Kim, J. S., & Kim, D. Y. (2018) · Journal of Ophthalmology · doi:10.1155/2018/4258763 · Cited by 7
Clinical research of fenofibrate and spironolactone for acute central serous chorioretinopathy
Chai, Y., Liu, R., Yi, J., Ye, L.-H., Zou, J., Jiang, N., & Shao, Y. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.10.13 · Cited by 4
Cited by
Spaide, R. F., Gemmy Cheung, C. M., Matsumoto, H., Kishi, S., Boon, C. J. F., van Dijk, E. H. C., Mauget-Faysse, M., Behar-Cohen, F., Hartnett, M. E., Sivaprasad, S., et al. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100973 · Cited by 372
Self-citation
Metadata
- Authors
- van Rijssen, T. J., van Dijk, E. H. C., Yzer, S., Ohno-Matsui, K., Keunen, J. E. E., Schlingemann, R. O., Sivaprasad, S., Querques, G., Downes, S. M., Fauser, S., Hoyng, C. B., Piccolino, F. C., Chhablani, J. K., Lai, T. Y. Y., Lotery, A. J., Larsen, M., Holz, F. G., Freund, K. B., Yannuzzi, L. A., & Boon, C. J. F.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 73
- Pages
- 100770
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2958114009
- Cited by
- 478
- References
- 150
- FWCI
- 42.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.